ChemPartner PharmaTechLtd Balance Sheet Health
Financial Health criteria checks 6/6
ChemPartner PharmaTechLtd has a total shareholder equity of CN¥1.4B and total debt of CN¥136.0M, which brings its debt-to-equity ratio to 9.8%. Its total assets and total liabilities are CN¥2.2B and CN¥767.0M respectively.
Key information
9.8%
Debt to equity ratio
CN¥136.03m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥321.76m |
| Equity | CN¥1.39b |
| Total liabilities | CN¥766.98m |
| Total assets | CN¥2.16b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300149's short term assets (CN¥624.0M) exceed its short term liabilities (CN¥347.2M).
Long Term Liabilities: 300149's short term assets (CN¥624.0M) exceed its long term liabilities (CN¥419.8M).
Debt to Equity History and Analysis
Debt Level: 300149 has more cash than its total debt.
Reducing Debt: 300149's debt to equity ratio has reduced from 34.4% to 9.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 300149 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 300149 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 7.2% per year.